Top Markets
Coin of the day
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Clasificación en acciones #11956
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Precio por acción
$10.30
Última sincronización: 2026-08-11
Capitalización bursátil
$638.32M
Cambio (1 día)
2.88%
Cambio (1 año)
-
País
CA
Comercio Cybin Inc. Common Stock (HELP)

Categoría

Ratio P/B de Cybin Inc. Common Stock (HELP)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Cybin Inc. Common Stock, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Cybin Inc. Common Stock desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH